tiprankstipranks
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART

Integra Lifesciences (IART) Financial Statements

214 Followers

Integra Lifesciences Financial Overview

Integra Lifesciences's market cap is currently ―. The company's EPS TTM is $0.506; its P/E ratio is 56.68; Integra Lifesciences is scheduled to report earnings on July 24, 2024, and the estimated EPS forecast is $0.62. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 368.87M$ 382.42M$ 381.27M$ 380.85M$ 398.02M
Gross Profit$ 206.83M$ 218.34M$ 207.03M$ 232.87M$ 250.09M
EBIT$ 8.39M$ 31.67M$ 16.29M$ 41.88M$ 77.10M
EBITDA$ 38.96M$ 62.23M$ 47.11M$ 73.02M$ 106.60M
Net Income Common Stockholders$ -3.28M$ 19.50M$ 4.18M$ 24.23M$ 52.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 663.10M$ 273.73M$ 309.19M$ 307.37M$ 456.66M
Total Assets$ 4.08B$ 3.74B$ 3.78B$ 3.74B$ 3.89B
Total Debt$ 2.04B$ 1.69B$ 1.60B$ 1.51B$ 1.62B
Net Debt$ 1.38B$ 1.41B$ 1.29B$ 1.20B$ 1.16B
Total Liabilities$ 2.48B$ 2.16B$ 2.09B$ 2.07B$ 2.09B
Stockholders Equity$ 1.60B$ 1.58B$ 1.68B$ 1.67B$ 1.80B
Cash Flow-
Free Cash Flow$ 291.00K$ 11.49M$ 11.35M$ 7.75M$ 70.88M
Operating Cash Flow$ 15.76M$ 24.57M$ 26.90M$ 21.46M$ 85.33M
Investing Cash Flow$ -53.97M$ -5.50M$ -14.17M$ -9.01M$ -54.82M
Financing Cash Flow$ 358.68M$ -49.66M$ -10.69M$ -162.68M$ -97.70M
Currency in USD

Integra Lifesciences Earnings and Revenue History

Integra Lifesciences Debt to Assets

Integra Lifesciences Cash Flow

Integra Lifesciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis